Victoza and Nicotinamide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Victoza (liraglutide) and Nicotinamide (niacin and niacinamide (vitamin b3)). Common drug interactions include infusion site haemorrhage among females and international normalised ratio increased among males.

The phase IV clinical study analyzes what interactions people have when they take Victoza and Nicotinamide. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Victoza?

Victoza has active ingredients of liraglutide. It is often used in diabetes. eHealthMe is studying from 42,880 Victoza users. Check the latest studies of Victoza.

What is Nicotinamide?

Nicotinamide has active ingredients of niacin and niacinamide (vitamin b3). eHealthMe is studying from 1,991 Nicotinamide users. Check the latest studies of Nicotinamide.

On Aug, 02, 2026

18 people who take Victoza and Nicotinamide together, and have interactions are studied.

Victoza and Nicotinamide drug interactions.

What are the common drug interactions of Victoza and Nicotinamide, by gender? *:

female:

Infusion site haemorrhage (bleeding from infusion site)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Pneumonia
Multiple allergies (allergy to multiple agents)
Surgery
Viral infection
Urinary tract infection
Upper limb fracture
Blood calcium increased
Cardiac failure congestive

male:

International normalised ratio increased
Asthenia (weakness)
Blood creatinine increased
Blood testosterone decreased
Chest pain
Hepatic enzyme increased
Hepatic steatosis (fatty liver disease)
Retching (strong involuntary effort to vomit)
Tremor (trembling or shaking movements in one or more parts of your body)
Weight increased

What are the common drug interactions of Victoza and Nicotinamide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Asthenia (weakness)
Blood testosterone decreased
Hepatic enzyme increased
Hepatic steatosis (fatty liver disease)
Retching (strong involuntary effort to vomit)

40-49:

n/a

50-59:

Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Infusion site haemorrhage (bleeding from infusion site)
Pneumonia
Multiple allergies (allergy to multiple agents)
Surgery
Viral infection
Urinary tract infection
International normalised ratio increased
Upper limb fracture

60+:

Blood calcium increased
Cardiac failure congestive
Pain in extremity
Peripheral swelling
Vomiting
Weight decreased
Cellulitis (infection under the skin)
Chronic kidney disease
Confusional state
Dyspnoea (difficult or laboured respiration)

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 9 people, 50.00%
High Blood Pressure: 3 people, 16.67%
Weight Loss: 2 people, 11.11%
Type 2 Diabetes: 2 people, 11.11%
Renal Disorder (kidney disease): 2 people, 11.11%
Psoriasis (immune-mediated disease that affects the skin): 2 people, 11.11%
Phobia (fear): 2 people, 11.11%
Peripheral Swelling: 2 people, 11.11%
Hyperkalemia (damage to or disease of the kidney): 2 people, 11.11%
Hidradenitis (chronic disease of a type of sweat gland): 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Victoza and Nicotinamide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously